Public Information


Health Canada approves PLUVICTO™ as first targeted radioligand therapy for progressive PSMA positive metastatic castration-resistant prostate cancer


Health Canada has authorized PLUVICTO™ for the treatment of certain patients with progressive, prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer.

 

Specifically, PLUVICTO™ has been approved for the treatment of adult patients with PSMA-positive mCRPC who have received at least one androgen receptor pathway inhibitor (ARPI) and taxane-based chemotherapy.


The press release to announce this news is available HERE:

Health Canada approves PLUVICTO as first targeted radioligand therapy for progressive PSMA positive metastatic castration-resistant prostate cancer | Novartis Canada


 




------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




INESSS DaTscan recommendation


The Quebec’s Institut national d'excellence en santé et en services sociaux (INESSS) became the first Canadian health technology assessment organization to review DaTscan ([123I]ioflupane)and has provided a positive reimbursement recommendation.


For the full summary, see the documents below or you may consult the INESSS website for more information.


INESSS_Ioflupane_Aide-Memoire 20210823.pdf

INESSS_Ioflupane_Avis 20210823.pdf


------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



June 30th, 2021 - The Evolution of Cardiac PET: Two perspectives from starting a program and evolving to acute care


Session #1 Speakers:   Dr. Katherine Zukotynski and Dr. Vikas Tandon

Session #2 Speaker:  Dr. Matthieu Pelletier Galarneau


Video link:     Video


This webinar was sponsored by :  




**********************************



INTRODUCTION TO NUCLEAR MEDICINE


Click to View


FDG PET STUDY

Click to View


CARDIAC STUDY

Click to View

 

PULMONARY STUDY


Click to View 


BONE STUDY

Click to View

 

Powered by Wild Apricot Membership Software